Trials / Completed
CompletedNCT02663479
Nutraceutical Supplement in the Management of Hypertension
Proprietary Lipid-Lowering Nutraceutical Supplement in the Management of Hypertension
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Thorne HealthTech, Inc · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of a proprietary nutraceutical supplement in capsule form over 4 months in treating blood pressure in a group of chronic hypertensive subjects that are not receiving any pharmaceutical anti-hypertensive agents or other nutraceutical supplements.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Cardiopressin | |
| DIETARY_SUPPLEMENT | Placebo |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2017-08-01
- Completion
- 2017-10-01
- First posted
- 2016-01-26
- Last updated
- 2020-03-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02663479. Inclusion in this directory is not an endorsement.